lobbying_activities: 2599116
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2599116 | 2013a1bf-32df-43ee-8994-0fe718f02ab1 | Q1 | FORBES-TATE | 400976792 | NOVARTIS, INC. | 2021 | first_quarter | CPT | Issues related to prescription drug pricing and Intellectual Property (IP); Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2). | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-04-17T11:27:20.690000-04:00 |